Abstract
Beckwith–Wiedemann syndrome is an overgrowth disorder characterized by neonatal macrosomia, abdominal wall defects, macroglossia, renal anomalies, organomegaly, hypoglycemia, and cancer predisposition. Hepatoblastoma is the second most frequent tumor and periodic serum alpha-fetoprotein (αFP) dosage is the cornerstone of the tumor surveillance for its early detection. In this report, we describe the outstanding case of a Beckwith–Wiedemann syndrome (BWS) newborn with severe phenotype and paternal chromosome 11 uniparental disomy (UPD11) associated with a high tumor risk. Based on the clinical picture and previous reports, a close monitoring of αFP was commenced. The marker was normal immediately after birth, but rapidly raised in 20 days, leading to the diagnosis of an extremely aggressive hepatoblastoma. The latter was successfully treated with pre-surgical reductive chemotherapy, gross total mass resection, and subsequent chemotherapy. Based on this observation, the tumor surveillance routinely suggested every 3 months should be more intense and with closer time intervals in newborns with severe BWS phenotype. We suggest monitoring neonatal αFP every 20 days in such cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bader D, Riskin A, Vafsi O et al (2004) Alpha-fetoprotein in the early neonatal period—a large study and review of the literature. Clin Chim Acta 349:15–23
Bliek J, Gicquel C, Maas S et al (2004) Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith–Wiedemann syndrome (BWS). J Pediatr 145:796–799
Blohm ME, Vesterling-Hörner D, Calaminus G, Göbel U (1998) Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol 15:135–142
Clericuzio CL, Martin RA (2009) Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia. Genet Med 11:220–222
Clericuzio CL, Chen E, McNeil DE et al (2003) Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith–Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 143:270–272
Cooper WN, Luharia A, Evans GA et al (2005) Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndrome. Eur J Hum Genet 13:1025–1032
DeBaun MR, Tucker MA (1998) Risk of cancer during the first four years of life in children from the Beckwith–Wiedemann Syndrome Registry. J Pediatr 132:398–400
Enklaar T, Zabel BU, Prawitt D (2006) Beckwith–Wiedemann syndrome: multiple molecular mechanisms. Expert Rev Mol Med 8:1–19
Everman DB, Shuman C, Dzolganovski B et al (2000) Serum alpha-fetoprotein levels in Beckwith–Wiedemann syndrome. J Pediatr 137:123–127
Herzog CE, Andrassy RJ, Eftekhari F (2000) Childhood cancers: hepatoblastoma. Oncologist 5:445–453
Kapoor RR, James C, Hussain K (2009) Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Metab 5:101–112
Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 137:53–71
Munns CF, Batch JA (2001) Hyperinsulinism and Beckwith–Wiedemann syndrome. Arch Dis Child Fetal Neonatal Ed 84:F67–F69
Orozco-Florian R, McBride JA, Favara BE (1991) Congenital hepatoblastoma and Beckwith–Wiedemann syndrome: a case study including DNA ploidy profiles of tumor and adrenal cytomegaly. Pediatr Pathol 11:131–142
Rump P, Zeegers MP, van Essen AJ (2005) Tumor risk in Beckwith–Wiedemann syndrome: a review and meta-analysis. Am J Med Genet A 136:95–104
Smith AC, Shuman C, Chitayat D et al (2007) Severe presentation of Beckwith–Wiedemann syndrome associated with high levels of constitutional paternal uniparental disomy for chromosome 11p15. Am J Med Genet A 143A:3010–3015
Sparago A, Cerrato F, Vernucci M et al (2004) Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith–Wiedemann syndrome. Nat Genet 36:958–960
Sparago A, Russo S, Cerrato F et al (2007) Mechanisms causing imprinting defects in familial Beckwith–Wiedemann syndrome with Wilms' tumour. Hum Mol Genet 16:254–264
Tan TY, Amor DJ (2006) Tumour surveillance in Beckwith–Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 42:486–490
Weksberg R, Shuman C, Beckwith JB (2010) Beckwith–Wiedemann syndrome. Eur J Hum Genet 18:8–14
Worth LL, Slopis JM, Herzog CE (1999) Congenital hepatoblastoma and schizencephaly in an infant with Beckwith–Wiedemann syndrome. Med Pediatr Oncol 33:591–593
Conflict of interest
The authors disclose that they have no competing financial interest with respect to this article. No funding source supported this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mussa, A., Ferrero, G.B., Ceoloni, B. et al. Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith–Wiedemann syndrome. Eur J Pediatr 170, 1407–1411 (2011). https://doi.org/10.1007/s00431-011-1455-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-011-1455-0